Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Leukemia Acute Myeloid Leukemia (AML): early-phase trial registry

1 of 1 indexed Leukemia Acute Myeloid Leukemia (AML) trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Leukemia Acute Myeloid Leukemia (AML): 1 US clinical trial tracked, 1 recruiting.

Leukemia Acute Myeloid Leukemia (AML) is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is SillaJen, running 1 of these trials.

Enrollment posture brief

Registry condition leukemia-acute-myeloid-leukemia-aml

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Leukemia Acute Myeloid L (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Leukemia Acute Myeloid Leukemia (AML)

Leukemia Acute Myeloid Leukemia (AML) lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Leukemia Acute Myeloid Leukemia (AML) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Leukemia Acute Myeloid Leukemia (AML) is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

SillaJen 1 trials

Named interventions

Most-linked intervention names on Leukemia Acute Myeloid Leukemia (AML) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Paclitaxel Combination
1 trials
Tislelizumab Combination
1 trials
BAL0891 Drug
1 trials

US sites by state

Facility locations filed on Leukemia Acute Myeloid Leukemia (AML) trials. A trial with sites in several states counts in each.

Texas 1 trials
Oregon 1 trials
New York 1 trials
Florida 1 trials
Connecticut 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Leukemia Acute Myeloid Leukemia (AML) page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Leukemia Acute Myeloid Leukemia (AML) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • SillaJen sponsors the most Leukemia Acute Myeloid Leukemia (AML) trials on record, review their full trial history before evaluating a specific study. See SillaJen's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Leukemia Acute Myeloid Leukemia (AML) condition card totals 1 registered trials; most-linked intervention Paclitaxel; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.